Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

The CXCR4-CXCL12/SDF-1 pathway is a possible target for non-Hodgkin's lymphoma therapy

Aug. 12, 2002

Novel HDAC inhibitors identified at Beacon

Aug. 9, 2002

Pivotal phase III trial of RSR-13 completes enrollment

Aug. 9, 2002

Little or no activity for KW-2189 in advanced malignant melanoma

Aug. 9, 2002

Servier researchers identify new metalloproteinase inhibitors

Aug. 8, 2002

Bayer claims new PDE10A inhibitors and their use in cancer

Aug. 8, 2002

AstraZeneca completes Iressa NDA for NSCLC

Aug. 8, 2002

Positive results for ursodiol in colorectal cancer

Aug. 8, 2002

Introgen to file European Advexin marketing application in 2004

Aug. 8, 2002

Atrix submits IND for new dosage form of Eligard

Aug. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...